Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 0 | 0 | 0 | 97 | 137 |
| Gross Profit | N/A | N/A | N/A | 97 | 137 |
| Operating Expenses | 12,340 | 8,517 | 9,998 | 13,973 | 16,838 |
| Operating Income | -12,340 | -8,517 | -9,998 | -13,875 | -16,701 |
| Interest Expense | 490 | 0 | 0 | 0 | 0 |
| Other Income | -419 | -920 | -262 | 11,699 | -437 |
| Pre-tax Income | -13,249 | -9,437 | -10,261 | -2,176 | -17,138 |
| Net Income Continuous | -13,249 | -9,437 | -10,261 | -2,176 | -17,138 |
| Net Income | $-13,249 | $-9,437 | $-10,261 | $-2,176 | $-17,138 |
| EPS Basic Total Ops | -3.18 | -2.26 | -1.84 | -0.60 | -4.50 |
| EPS Basic Continuous Ops | -3.18 | -2.26 | -2.05 | -0.52 | -4.42 |
| EPS Diluted Total Ops | -3.18 | -2.26 | -1.84 | -0.60 | -4.50 |
| EPS Diluted Continuous Ops | -3.18 | -2.26 | -2.05 | -0.52 | -4.42 |
| EBITDA(a) | $-11,761 | $-7,690 | $-9,192 | $-12,986 | $-15,953 |